Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Losartan 100mg tablets
0205052N0AAADAD
|
Losartan potassium | Losartan potassium | Cardiovascular System | 921,917 |
|
Losartan 50mg tablets
0205052N0AAABAB
|
Losartan potassium | Losartan potassium | Cardiovascular System | 800,503 |
|
Losartan 25mg tablets
0205052N0AAAAAA
|
Losartan potassium | Losartan potassium | Cardiovascular System | 501,938 |
|
Losartan 12.5mg tablets
0205052N0AAAHAH
|
Losartan potassium | Losartan potassium | Cardiovascular System | 97,970 |
|
Losartan 50mg/5ml oral suspension
0205052N0AAAJAJ
|
Losartan potassium | Losartan potassium | Cardiovascular System | 555 |
|
Losartan 50mg/5ml oral solution
0205052N0AAAEAE
|
Losartan potassium | Losartan potassium | Cardiovascular System | 184 |
|
Losartan 100mg/5ml oral liquid
0205052N0AAAFAF
|
Losartan potassium | Losartan potassium | Cardiovascular System | 29 |
|
Losartan 12.5mg/5ml oral suspension
0205052N0AAALAL
|
Losartan potassium | Losartan potassium | Cardiovascular System | 10 |
|
Losartan 2.5mg/ml oral suspension sugar free
0205052N0AAAIAI
|
Losartan potassium | Losartan potassium | Cardiovascular System | 1 |
|
Losartan 20mg/5ml oral suspension
0205052N0AAAKAK
|
Losartan potassium | Losartan potassium | Cardiovascular System | No data available |
|
Losartan 25mg/5ml oral liquid
0205052N0AAAGAG
|
Losartan potassium | Losartan potassium | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.